Chronic Myeloid Leukemia Treatment Discontinuation https://shar.es/1C1jsb
the question is, when should we consider treatment discontinuation? Under what conditions? Is it something that you just do on patients or is it in clinical trial?
Chronic Myeloid Leukemia Treatment Discontinuation
Started by
Buzzm1
, Feb 22 2016 01:36 PM
1 reply to this topic
#1
Buzzm1
-
- Members
-
- 954 posts
Advanced Member
- LocationSilicon Valley
Posted 22 February 2016 - 01:36 PM
For the benefit of yourself and others please add your CML history into your Signature
02/2010 Gleevec 400mg
2011 Two weakly positives, PCRU, weakly positive
2012 PCRU, PCRU, PCRU, PCRU
2013 PCRU, PCRU, PCRU, weakly positive
2014 PCRU, PCRU, PCRU, PCRU (12/07 began dose reduction w/each continuing PCRU)
2015 300, 250, 200, 150
2016 100, 50/100, 100, 10/17 TFR
2017 01/17 TFR, 04/18 TFR, 07/18 TFR 0.0012, 08/29 TFR 0.001, 10/17 TFR 0.000
2018 01/16 TFR PCR result pending... next quarterly PCR 04/17
At the earliest opportunity, and whenever possible, lower your TKI dosage; TKIs are toxic drugs and the less we take longterm the better off we are going to be ... this is especially true for older adults.
In hindsight I should have started my dosage reduction two years earlier; it might have helped minimize some of the longterm cumulative toxic effects of TKIs that I am beset with.
longterm side-effects Peripheral Artery Disease - legs (it's a bitch); continuing shoulder problems, right elbow inflammation. GFR and creatinine vastly improved after stopping Gleevec.
Cumulative Gleevec dosage estimated at 830 grams
Taking Gleevec 400mg an hour after my largest meal of the day helped eliminate the nausea that Gleevec is notorious for.
Trey's CML Blog - Stopping - The Odds - Stop Studies - Discussion Forum Cessation Study
Big PhRMA - Medicare Status - Social Security Status - Deficit/Debt
#2
survenant
-
- Members
-
- 98 posts
Advanced Member
1 user(s) are reading this topic
0 members, 1 guests, 0 anonymous users
